These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26150116)

  • 1. Does PLGA microparticle swelling control drug release? New insight based on single particle swelling studies.
    Gasmi H; Danede F; Siepmann J; Siepmann F
    J Control Release; 2015 Sep; 213():120-127. PubMed ID: 26150116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a better understanding of the different release phases from PLGA microparticles: Dexamethasone-loaded systems.
    Gasmi H; Siepmann F; Hamoudi MC; Danede F; Verin J; Willart JF; Siepmann J
    Int J Pharm; 2016 Nov; 514(1):189-199. PubMed ID: 27543353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketoprofen-poly(D,L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics.
    Gabor F; Ertl B; Wirth M; Mallinger R
    J Microencapsul; 1999; 16(1):1-12. PubMed ID: 9972498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term controlled release of PLGA microparticles containing antidepressant mirtazapine.
    Vysloužil J; Doležel P; Kejdušová M; Košťál V; Beneš L; Dvořáčková K
    Pharm Dev Technol; 2016 Mar; 21(2):214-21. PubMed ID: 25495857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug release from PLGA-based microparticles: effects of the "microparticle:bulk fluid" ratio.
    Klose D; Siepmann F; Willart JF; Descamps M; Siepmann J
    Int J Pharm; 2010 Jan; 383(1-2):123-31. PubMed ID: 19748558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying drug release from PLGA nanoparticulates.
    Corrigan OI; Li X
    Eur J Pharm Sci; 2009 Jun; 37(3-4):477-85. PubMed ID: 19379812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and development of a novel controlled release PLGA alginate-pectinate polyspheric drug delivery system.
    Sweet JL; Pillay V; Choonara YE
    Drug Deliv; 2007 Jul; 14(5):309-18. PubMed ID: 17613019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic explanation of the (up to) 3 release phases of PLGA microparticles: Monolithic dispersions studied at lower temperatures.
    Tamani F; Bassand C; Hamoudi MC; Siepmann F; Siepmann J
    Int J Pharm; 2021 Mar; 596():120220. PubMed ID: 33486018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compressed biodegradable matrices of spray-dried PLGA microspheres for the modified release of ketoprofen.
    Gavini E; Sanna V; Juliano C; Giunchedi P
    J Microencapsul; 2003; 20(2):193-201. PubMed ID: 12554374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seeing is believing, PLGA microsphere degradation revealed in PLGA microsphere/PVA hydrogel composites.
    Gu B; Sun X; Papadimitrakopoulos F; Burgess DJ
    J Control Release; 2016 Apr; 228():170-178. PubMed ID: 26965956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic explanation of the (up to) 3 release phases of PLGA microparticles: Diprophylline dispersions.
    Tamani F; Bassand C; Hamoudi MC; Danede F; Willart JF; Siepmann F; Siepmann J
    Int J Pharm; 2019 Dec; 572():118819. PubMed ID: 31726196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and investigation of P28GST-loaded PLGA microparticles for immunomodulation of experimental colitis.
    Thi THH; Priemel PA; Karrout Y; Driss V; Delbeke M; Dendooven A; Flament MP; Capron M; Siepmann J
    Int J Pharm; 2017 Nov; 533(1):26-33. PubMed ID: 28923765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles.
    Klose D; Delplace C; Siepmann J
    Int J Pharm; 2011 Feb; 404(1-2):75-82. PubMed ID: 21056644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained release of risperidone from biodegradable microspheres prepared by in-situ suspension-evaporation process.
    An T; Choi J; Kim A; Lee JH; Nam Y; Park J; Sun Bk; Suh H; Kim CJ; Hwang SJ
    Int J Pharm; 2016 Apr; 503(1-2):8-15. PubMed ID: 26899975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Issues in long-term protein delivery using biodegradable microparticles.
    Ye M; Kim S; Park K
    J Control Release; 2010 Sep; 146(2):241-60. PubMed ID: 20493221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro.
    Fernández-Carballido A; Herrero-Vanrell R; Molina-Martínez IT; Pastoriza P
    Int J Pharm; 2004 Jul; 279(1-2):33-41. PubMed ID: 15234792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How porosity and size affect the drug release mechanisms from PLGA-based microparticles.
    Klose D; Siepmann F; Elkharraz K; Krenzlin S; Siepmann J
    Int J Pharm; 2006 May; 314(2):198-206. PubMed ID: 16504431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.
    Faisant N; Akiki J; Siepmann F; Benoit JP; Siepmann J
    Int J Pharm; 2006 May; 314(2):189-97. PubMed ID: 16510257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
    Klose D; Siepmann F; Elkharraz K; Siepmann J
    Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
    Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
    Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.